Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Skinbiotherap. (SBTX) Share Price

Price 11.25p on 11-03-2026 at 12:54:07
Change -0.75p -6.25%
Buy 11.50p
Sell 11.00p
Last Trade: Sell 455.00 at 11.021p
Day's Volume: 154,364
Last Close: 12.00p
Open: 12.00p
ISIN: GB00BF33H870
Day's Range 11.25p - 12.00p
52wk Range: 5.20p - 27.50p
Market Capitalisation: £29.16m
VWAP: 11.28641p
Shares in Issue: 259.17m

Skinbiotherap. (SBTX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 455 11.021p Ordinary
12:54:07 - 11-Mar-26
Sell* 2,495 11.0228p Ordinary
12:33:57 - 11-Mar-26
Sell* 18,076 11.065p Ordinary
12:15:13 - 11-Mar-26
Sell* 20,656 11.06p Ordinary
11:58:21 - 11-Mar-26
Sell* 250 11.00p SI Trade
11:46:59 - 11-Mar-26
Sell* 14,546 11.07p Ordinary
11:46:56 - 11-Mar-26
Buy* 869 11.50p SI Trade
11:27:24 - 11-Mar-26
Sell* 20,463 11.21p Ordinary
11:13:19 - 11-Mar-26
Buy* 4,189 11.84p Ordinary
10:57:52 - 11-Mar-26
Sell* 11,439 11.26p Ordinary
10:01:01 - 11-Mar-26
See more Skinbiotherap. trades

Skinbiotherap. (SBTX) Share Price History

Time period:
to
Date Open High Low Close Volume
11th Mar 2026 (Wed) 12.00 12.00 11.25 12.00 154,364
10th Mar 2026 (Tue) 11.75 12.25 11.75 12.00 500,437
9th Mar 2026 (Mon) 12.50 13.00 11.75 11.75 3,287,742
6th Mar 2026 (Fri) 10.50 13.25 11.75 12.50 7,622,031
5th Mar 2026 (Thu) 9.50 10.75 9.50 10.75 1,766,306
4th Mar 2026 (Wed) 9.50 9.56 9.56 9.56 1,139,108
3rd Mar 2026 (Tue) 9.25 9.80 9.25 9.50 5,860,338
2nd Mar 2026 (Mon) 8.00 9.32 9.32 9.32 4,121,416
27th Feb 2026 (Fri) 7.75 8.00 8.00 8.00 2,901,529
26th Feb 2026 (Thu) 7.25 8.00 7.75 7.75 8,368,464
25th Feb 2026 (Wed) 6.25 7.75 6.25 7.25 12,411,853
24th Feb 2026 (Tue) 5.25 6.25 5.25 6.25 5,649,235
23rd Feb 2026 (Mon) 5.25 5.25 5.25 5.25 2,631,819
20th Feb 2026 (Fri) 5.75 5.60 5.20 5.20 6,695,194
19th Feb 2026 (Thu) 5.90 5.90 5.25 5.75 6,126,382
18th Feb 2026 (Wed) 6.25 6.00 6.00 6.00 4,407,885
17th Feb 2026 (Tue) 6.25 7.25 5.75 6.35 13,007,438
16th Feb 2026 (Mon) 6.25 7.00 6.00 6.00 33,138,804
13th Feb 2026 (Fri) 14.00 14.75 12.25 12.375 108,765,422
12th Feb 2026 (Thu) 19.75 19.75 19.50 19.50 263,426
11th Feb 2026 (Wed) 19.75 19.75 19.75 19.75 689,428
See more Skinbiotherap. price history

Skinbiotherap. (SBTX) Regulatory News

Date Source Headline
9th Mar 2026 7:00 am RNS Appointment of the Interim CEO to the Board
2nd Mar 2026 7:00 am RNS Appointment of Interim CEO
20th Feb 2026 7:00 am RNS Independent Investigation Appointment
16th Feb 2026 7:00 am RNS Update on Board Investigation
13th Feb 2026 7:00 am RNS Resignation of CEO
12th Feb 2026 11:00 am RNS Holding(s) in Company
11th Feb 2026 7:00 am RNS Issue of Equity and Total Voting Rights
29th Jan 2026 7:00 am RNS Holding(s) in Company
22nd Jan 2026 9:00 am RNS Total Voting Rights
20th Jan 2026 7:00 am RNS Holding(s) in Company
See more Skinbiotherap. regulatory news

Skinbiotherap. (SBTX) Share News

SkinBioTherapeutics adds interim CEO Rachel Parsonage to board

9th Mar 2026 14:35

(Alliance News) - SkinBioTherapeutics on Monday confirmed the appointment of Interim Chief Executive Officer Rachel Parsonage to its board after completing regulatory due diligence. Read More

SkinBioTherapeutics appoints interim CEO as investigation continues

2nd Mar 2026 16:27

(Alliance News) - SkinBioTherapeutics PLC on Monday announced Rachel Parsonage has been appointed as interim chief executive officer effective immediately as the life science firm tries to carve out a way forward from the suspension and resignation of its past CEO. Read More

LONDON MARKET CLOSE: FTSE 100 climbs on strong retail sales data

20th Feb 2026 16:56

(Alliance News) - Stock prices in London closed higher on Friday, as a swathe of domestic economic data was well-received and the US Supreme Court ruled President Donald Trump's tariff programme is illegal. Read More

IN BRIEF: SkinBioTherapeutics board member to oversee external probe

20th Feb 2026 13:30

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life sciences - Non-Executive Director Alyson Levett will oversee an independent investigation of the events that led to the departure of Stuart Ashman as chief executive officer. Levett, who chairs the board's audit committee, will work with FRP Advisory, which the board has engaged to undertake a "forensic review". Read More

AIM WINNERS & LOSERS: Pulsar Helium raises GBP7 million in placing

20th Feb 2026 10:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

See more Skinbiotherap. news
FTSE 100 Latest
Value10,319.48
Change-92.76

Login to your account

Forgot Password?

Not Registered